Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Publication | Closed Access

DOI

497

Citations

References

2012

Year

Jorg R. Oddens, Maurizio Brausi, Richard Sylvester, Aldo Bono, C. van de Beek, George van Andel, Paolo Gontero, Wolfgang Hoeltl, Levent Türkeri, Sandrine Marréaud,

European Urology

Urological ResearchUrologyMaintenance Bacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary CancerMedicineOncologyRadiation OncologyCancer ResearchFinal ResultsUrinary Bladder